Soleus Capital Management, L.P. Portfolio Holdings

Soleus Capital Management, L.P.

  • $1.64 Billion
  • Q3 2025

Soleus Capital Management, L.P. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.64 Billion distributed in 88 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $180M, Tg Therapeutics, Inc. with a value of $139M, Novo Cure LTD with a value of $125M, Elevance Health, Inc. with a value of $83.9M, and United Therapeutics Corp with a value of $62.9M.

Examining the 13F form we can see an increase of $354M in the current position value, from $1.29B to 1.64B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.64 Billion
Healthcare: $1.53 Billion
ETFs: $115 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 88
  • Current Value $1.64 Billion
  • Prior Value $1.29 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 18 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email